Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing: earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures gives cross-border investors faster access to Tokyo-listed disclosures.
This corporate disclosure from AFC-HD AMS Life Science Co.,Ltd. was processed by Pulse News Wire on June 18, 2026. It represents a primary source document for Japanese Buyback sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.
TOKYO, Jun 18 (Pulse News Wire) – Afc-Hd AMS Life Science has authorised a share repurchase programme capped at 100 Million Yen (6.01% of issued shares excluding treasury). Afc-Hd AMS Life Science ci
View all AFC-HD AMS Life Science Co.,Ltd. disclosures →
AFC-HD AMS Life Science Co.,Ltd. [2927.T]
TOKYO, Jun 18 (Pulse News Wire) – Afc-Hd AMS Life Science has authorised a share repurchase programme capped at 100 Million Yen (6.01% of issued shares excluding treasury).
Afc-Hd AMS Life Science cited enhancing shareholder value as the rationale for the action.
🟢 Confidence: High AI-translated content.